BG102879A - Carbolin derivatives - Google Patents

Carbolin derivatives

Info

Publication number
BG102879A
BG102879A BG102879A BG10287998A BG102879A BG 102879 A BG102879 A BG 102879A BG 102879 A BG102879 A BG 102879A BG 10287998 A BG10287998 A BG 10287998A BG 102879 A BG102879 A BG 102879A
Authority
BG
Bulgaria
Prior art keywords
derivatives
carbolin
carbolin derivatives
thecarboline
formula32
Prior art date
Application number
BG102879A
Other languages
Bulgarian (bg)
English (en)
Inventor
Agnes Bombrun
Original Assignee
Icos Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609820.7A external-priority patent/GB9609820D0/en
Priority claimed from GBGB9609777.9A external-priority patent/GB9609777D0/en
Application filed by Icos Corporation filed Critical Icos Corporation
Publication of BG102879A publication Critical patent/BG102879A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG102879A 1996-05-10 1998-10-29 Carbolin derivatives BG102879A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9609820.7A GB9609820D0 (en) 1996-05-10 1996-05-10 Chemical compounds
GBGB9609777.9A GB9609777D0 (en) 1996-05-10 1996-05-10 Chemical compounds
PCT/EP1997/002277 WO1997043287A1 (fr) 1996-05-10 1997-05-05 Derives de carboline

Publications (1)

Publication Number Publication Date
BG102879A true BG102879A (en) 1999-09-30

Family

ID=26309303

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102879A BG102879A (en) 1996-05-10 1998-10-29 Carbolin derivatives

Country Status (26)

Country Link
US (2) US6117881A (fr)
EP (1) EP0912567B1 (fr)
JP (1) JP3418405B2 (fr)
KR (1) KR20000010918A (fr)
CN (1) CN1067071C (fr)
AP (1) AP9801365A0 (fr)
AT (1) ATE215950T1 (fr)
AU (1) AU711885B2 (fr)
BG (1) BG102879A (fr)
BR (1) BR9709230A (fr)
CA (1) CA2253948C (fr)
CZ (1) CZ358598A3 (fr)
DE (1) DE69711882T2 (fr)
EA (1) EA199800907A1 (fr)
EE (1) EE9800390A (fr)
ES (1) ES2175404T3 (fr)
HU (1) HUP9901478A3 (fr)
IL (1) IL126951A0 (fr)
IS (1) IS4864A (fr)
NO (1) NO985222L (fr)
OA (1) OA10920A (fr)
PL (1) PL329875A1 (fr)
SK (1) SK154498A3 (fr)
TR (1) TR199802282T2 (fr)
WO (1) WO1997043287A1 (fr)
YU (1) YU49898A (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9709230A (pt) * 1996-05-10 1999-08-10 Icos Corp Composto
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
DE19837069C1 (de) 1998-08-17 2000-01-05 Bayer Ag Substituierte Zimtsäuren und Zimtsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von substituierten Indanoncarbonsäureestern
US6462047B1 (en) * 1998-09-16 2002-10-08 Icos Corporation Carboline derivatives as cGMP phosphodiesterase inhibitors
DE19903087A1 (de) * 1999-01-27 2000-08-10 Forssmann Wolf Georg Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern
WO2000056304A2 (fr) * 1999-03-24 2000-09-28 Harbor Branch Oceanographic Institution, Inc. Utilisation de manzamines en tant qu'anti-inflammatoires
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
MXPA00003997A (es) 1999-04-30 2002-03-08 Lilly Icos Llc Articulos de fabricacion.
AU5584901A (en) 2000-04-19 2001-10-30 Icos Corp Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
UA74826C2 (en) 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
CA2412596C (fr) 2000-06-23 2007-07-31 Lilly Icos Llc Inhibiteurs de phosphodiesterase specifique de gmp cyclique
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
DE60216233T2 (de) * 2001-02-12 2007-09-27 Lilly Icos Llc, Wilmington Carbolinderivate
DE60112974T2 (de) 2001-02-12 2006-02-16 Lilly Icos Llc, Wilmington Carbolinderivate
US7115621B2 (en) * 2001-04-25 2006-10-03 Lilly Icos Llc Chemical compounds
CA2445460A1 (fr) 2001-06-05 2002-12-12 Lilly Icos Llc Derives de carboline utilises comme inhibiteurs de pde-5
ES2269679T3 (es) * 2001-06-21 2007-04-01 Lilly Icos Llc Derivados de carbolina como inhibidores de pdev.
WO2003042216A1 (fr) 2001-11-09 2003-05-22 Schering Corporation Inhibiteurs de la phosphodiesterase v de derives polycycliques de guanine
EP1458679B1 (fr) 2001-12-20 2010-01-20 Merck Serono SA Derives de pyrrolidine utilises en tant que modulateurs de la prostaglandine
TWI329111B (en) 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7595311B2 (en) 2002-05-24 2009-09-29 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
US20070010450A1 (en) 2003-06-13 2007-01-11 Microbia, Inc., A Massachusetts Corporation Methods and compositions for the treatment of gastrointestinal disorders
EP1637521B1 (fr) * 2003-06-23 2013-06-19 Ono Pharmaceutical Co., Ltd. Nouveau compose heterocyclique tricyclique
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
CN102408425A (zh) 2004-03-15 2012-04-11 Ptc医疗公司 用于抑制血管生成的咔啉衍生物及其应用
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
EP1757591A4 (fr) 2004-05-26 2010-05-05 Eisai R&D Man Co Ltd Composé de cinnamide
SA05260149B1 (ar) * 2004-05-26 2010-06-16 إيساي آر آند دي منجمنت كو.، ليمتد مركب سيناميد
JPWO2006046575A1 (ja) 2004-10-26 2008-05-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物の非晶質体
DK1829874T3 (da) 2004-12-22 2014-05-12 Ono Pharmaceutical Co Tricyklisk forbindelse og anvendelse deraf
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (fr) 2005-10-21 2008-07-09 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1956906A4 (fr) 2005-11-09 2009-12-30 Combinatorx Inc Procedes, compositions et kits pour le traitement de pathologies
US20090270623A1 (en) * 2005-11-18 2009-10-29 Naoyuki Shimomura Process for production of cinnamide derivative
JPWO2007058304A1 (ja) * 2005-11-18 2009-05-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物の塩またはそれらの溶媒和物
NZ568050A (en) 2005-11-24 2010-09-30 Eisai R&D Man Co Ltd Morpholine type cinnamide compound
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
US20070117839A1 (en) * 2005-11-24 2007-05-24 Eisai R&D Management Co., Ltd. Two cyclic cinnamide compound
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
SA07280403B1 (ar) 2006-07-28 2010-12-01 إيساي أر أند دي منجمنت كو. ليمتد ملح رباعي لمركب سيناميد
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008095136A2 (fr) 2007-01-31 2008-08-07 Henkin Robert I Procédés de détection de substances biologiques
TW200848054A (en) 2007-02-28 2008-12-16 Eisai R&D Man Co Ltd Two cyclic oxomorpholine derivatives
WO2008140111A1 (fr) * 2007-05-16 2008-11-20 Eisai R & D Management Co., Ltd. Procédé de production monotope pour un dérivé de cinnamide
AU2008292390B2 (en) 2007-08-31 2013-04-04 Eisai R & D Management Co., Ltd. Polycyclic compound
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
EP2239265A1 (fr) * 2008-01-28 2010-10-13 Eisai R&D Management Co., Ltd. Composés cristallins de cinnamide ou sels de ceux-ci
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014055801A1 (fr) 2012-10-05 2014-04-10 Henkin Robert I Inhibiteurs de la phosphodiestérase destinés à traiter des troubles du goût et de l'odorat
EP3108245B1 (fr) 2014-02-18 2020-07-22 Robert I. Henkin Procédés et compositions permettant de diagnostiquer et de traiter une perte et/ou une distorsion du goût ou de l'odorat
AU2016326718B2 (en) * 2015-09-23 2022-12-15 Minerva Biotechnologies Corporation Method of screening for agents for differentiating stem cells

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644384A (en) * 1969-06-09 1972-02-22 Sterling Drug Inc Certain 2-(alpha-haloacetyl) - 1 2 3 4-tetrahydro - 9h - pyrido(3 4-b)indole-3-carboxylates and derivatives
US3717638A (en) * 1971-03-11 1973-02-20 Sterling Drug Inc 1,2,3,4,6,7,12,12A-OCTAHYDRO-2-PHENYLPYRAZINO[2',1':6,1]PYRIDO[3,4-b]INDOLES AND INTERMEDIATES THEREFOR
US3917599A (en) * 1973-03-30 1975-11-04 Council Scient Ind Res 2-Substituted-1,2,3,4,6,7,12,12A-octahydropyrazino(2{40 ,1{40 :6,1)pyrido(3,4-B)indoles
GB1454171A (en) * 1973-10-19 1976-10-27 Council Scient Ind Res Tetracyclic compounds
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
GR79603B (fr) * 1982-07-24 1984-10-31 Pfizer
IT1217190B (it) * 1988-04-22 1990-03-14 Recordati Chem Pharm Composti utili per il trattamento e diagnosi di disfunzioni frettili
FI892362A (fi) * 1988-06-01 1989-12-02 Eisai Co Ltd Buten- eller propensyraderivat.
EP0357122A3 (fr) * 1988-08-29 1991-10-23 Duphar International Research B.V L'application des bêta-carbolines, benzofurane et benzothiophène analogues pour obtenir un médicament à activité cytostatique
DE3830096A1 (de) * 1988-09-03 1990-03-15 Hoechst Ag Piperazindione mit psychotroper wirkung
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
JPH0344324A (ja) * 1989-07-13 1991-02-26 Kazuoki Tsuchiya 性機能賦活剤
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
EP0459666B1 (fr) * 1990-05-31 1994-11-09 Pfizer Inc. Médicament contre l'impuissance
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9218322D0 (en) * 1992-08-28 1992-10-14 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
BR9709230A (pt) * 1996-05-10 1999-08-10 Icos Corp Composto
US5874437A (en) * 1996-11-01 1999-02-23 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives

Also Published As

Publication number Publication date
NO985222D0 (no) 1998-11-09
DE69711882T2 (de) 2002-10-31
TR199802282T2 (xx) 1999-03-22
IL126951A0 (en) 1999-09-22
US6306870B1 (en) 2001-10-23
EE9800390A (et) 1999-06-15
AP9801365A0 (en) 1998-12-31
WO1997043287A1 (fr) 1997-11-20
DE69711882D1 (en) 2002-05-16
ATE215950T1 (de) 2002-04-15
YU49898A (sh) 2000-03-21
EP0912567B1 (fr) 2002-04-10
US6117881A (en) 2000-09-12
CA2253948A1 (fr) 1997-11-20
ES2175404T3 (es) 2002-11-16
JP2000513717A (ja) 2000-10-17
HUP9901478A2 (hu) 1999-08-30
AU711885B2 (en) 1999-10-21
AU2891097A (en) 1997-12-05
IS4864A (is) 1998-10-13
EA199800907A1 (ru) 1999-04-29
HUP9901478A3 (en) 1999-11-29
JP3418405B2 (ja) 2003-06-23
KR20000010918A (ko) 2000-02-25
NO985222L (no) 1999-01-11
CN1067071C (zh) 2001-06-13
CZ358598A3 (cs) 1999-03-17
CN1218471A (zh) 1999-06-02
OA10920A (en) 2003-02-21
EP0912567A1 (fr) 1999-05-06
PL329875A1 (en) 1999-04-12
SK154498A3 (en) 2000-01-18
BR9709230A (pt) 1999-08-10
CA2253948C (fr) 2005-07-26

Similar Documents

Publication Publication Date Title
BG102879A (en) Carbolin derivatives
AU6230098A (en) Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
CA2257010A1 (fr) Methodes et compositions pour le traitement et la prevention des tumeurs, des troubles relies a des tumeurs et de la cachexie
MXPA02006212A (es) Inhibidores de fosfodiesterasa amp-especifica ciclica.
ZA9811178B (en) Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors.
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
CA2263561A1 (fr) Thienopyrimidines
HK1059562A1 (en) Novel trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of csbp/p38 kinase mediated diseases
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
WO2001044247A3 (fr) Agents et methodes de traitement des maladies hyperplasiques
HUP0103143A3 (en) Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase, process for their preparation and their use
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
WO2002009713A3 (fr) Inhibiteurs selectifs de pde 2 comme medicaments ameliorant la perception
NZ544591A (en) Pyrrolodihydroisoquinolines as PDE10 inhibitors
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
EP1027054A4 (fr) Apport local d'inhibiteurs de phosphodiesterases, dans le traitement du dysfonctionnement erectile
MXPA02006206A (es) Pirrolidinas que inhiben la pde camp-especifica.
WO1993000094A3 (fr) Utilisation de derives de tetrahydrobenzazepine pour le traitement de l'hypertension porte et de la migraine
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
IL127689A (en) Acryloyl substituted distamycin derivatives, process for preparing them and their use for the manufacture of antitumor and antiviral agents
MXPA04004372A (es) Derivados heterociclicos de glicinamida y su uso medico.
DE50211929D1 (en) Pyrimidinderivate
IL132599A0 (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use